22-20993955-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM1PP3_Moderate
The NM_006767.4(LZTR1):āc.1385T>Cā(p.Ile462Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0000124 in 1,612,694 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I462S) has been classified as Uncertain significance.
Frequency
Consequence
NM_006767.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LZTR1 | NM_006767.4 | c.1385T>C | p.Ile462Thr | missense_variant | 13/21 | ENST00000646124.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LZTR1 | ENST00000646124.2 | c.1385T>C | p.Ile462Thr | missense_variant | 13/21 | NM_006767.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152192Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000161 AC: 4AN: 247974Hom.: 0 AF XY: 0.0000298 AC XY: 4AN XY: 134450
GnomAD4 exome AF: 0.0000123 AC: 18AN: 1460502Hom.: 0 Cov.: 34 AF XY: 0.0000193 AC XY: 14AN XY: 726546
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152192Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 74348
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Dec 06, 2022 | Variant observed in a compound heterozygous state in an individual with suspected Noonan syndrome in the published literature (Pagnamenta 2019); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 30859559) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 16, 2023 | This sequence change replaces isoleucine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 462 of the LZTR1 protein (p.Ile462Thr). This variant is present in population databases (rs147684991, gnomAD 0.01%). This missense change has been observed in individual(s) with clinical features of autosomal recessive Noonan syndrome (PMID: 30859559). ClinVar contains an entry for this variant (Variation ID: 549756). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt LZTR1 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Hereditary cancer-predisposing syndrome;CN230736:Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 12, 2023 | The p.I462T variant (also known as c.1385T>C), located in coding exon 13 of the LZTR1 gene, results from a T to C substitution at nucleotide position 1385. The isoleucine at codon 462 is replaced by threonine, an amino acid with similar properties. This alteration was detected in a 28-year-old patient with features of Noonan syndrome who was also found to carry another LZTR1 variant in trans (Pagnamenta AT et al. Clin Genet, 2019 Jun;95:693-703). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Noonan syndrome 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | research | Genomic Medicine Theme, NIHR Oxford Biomedical Research Centre, University of Oxford | Jul 02, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at